Loading clinical trials...
Loading clinical trials...
Cognitive impairment is also a major risk factor for development of dementia later in life. Findings from the investigators studies suggest that the carotenoids, lutein and zeaxanthin may be important...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tufts University
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT06467539 · Alzheimer Disease, Mild Cognitive Impairment
NCT07220668 · Mild Cognitive Impairment
NCT04123314 · Depressive Symptoms, Depression, and more
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions